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Abstract
Introduction: Tetanus is a fatal infectious disease. It could cause typical signs like pain, headache,
stiffness, and spasms of facial muscles as well as trunk and skeletal muscles. The symptoms are risus
sardonicus, trismus and opisthotonus. How to control the spasticity and rigidity of muscles is still a
problem. Our object is to raise the feasibility of titration of high dose sedatives in the management of
severe tetanus.
Case presentation: A 37-year-old woman was sustained a 2 cm wound in the right anterior part of
chest. Then she developed progressive risus sardonicus, trismus and opisthotonus, elevated liver
enzymes, creatine kinase, lactic acid and myoglobin. The patient was treated with continuous infusion
of propofol (50-100 mg/h, 22 days) and midazolam (5-20 mg/h, 37 days) for sedation, vecuronium
(1-6 mg/h, 25 days) for muscle relaxation. The symptoms of tetanus were controlled, and there were
no side-effects appeared.
Conclusion: We report one case of severe tetanus. In this case, several types of sedative were
administrated and most of them were high doses. The patient recovered while no complications
remained. This case report indicated that combination and high dose of sedation for severe tetanus
were feasible. We recommend this treatment as the guidance of similar patients.
Introduction
Tetanus is an acute fatal infectious disease which is caused
by Clostridium tetani. The source of the infection is the
contaminated wound, which often remains unidentified.
Almost 1 million patients die of tetanus every year [1].
Clostridium tetani produces tetanus neurotoxin in anaero-
bic surroundings. Spreading to the central nervous system,
tetanus neurotoxin prevents the release of the inhibitory
neurotransmitter g-amino butyric acid and then causes
these typical symptoms of the disease [2]. Spasms are
provoked by minor stimuli like sounds or touching, so
physical examinations are difficult to perform. It has been
described autonomic instability leads to fever, hyperten-
sion, tachycardia, and hypersalivation. Early onset of
symptoms correlates with more severe disease. The
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while additional examinations are mainly done to exclude
other diseases. Wound cultures are positive for C. tetani in
only 30% of documented cases [3]. To prevent further
neurotoxins absorption by surgical treatments and neu-
tralizing neurotoxins is the aim of the treatment. For
eradicating C. tetani, both penicillin and metronidazole
are good choices. But high dose of penicillin in animal
models was suggested increasing risk of convulsion, while
metronidazole reduces the mortality and the stay in
hospital [4]. Tetanus is a self-limiting disease. In approxi-
mately 2 to 4 weeks, the tetanus neurotoxins will be
gradually cleared and the spasms will subside, but
autonomic dysfunction will be present for several
weeks [1].
Sedative is given in order to control the symptoms of
tetanus, but there was no report in the guidelines for the
doses of sedatives. In 1988, Helsinki University Central
Hospital treated a severe tetanus adult patient with long-
term infusions of propofol (20-80 mg/h, 11 days) and
midazolam (5-15 mg/h, 29 days) for sedation, as well as
vecuronium infusion (6-8 mg/h, 35 days) for muscle
relaxation, and the patient recovered at last [5]. In this
article, we treated our case of severe tetanus which was
given combination and high doses of sedatives.
Case presentation
Injured by firecracker on May 14th, 2008, a 37-year-old
woman of Chinese Han individual sustained a 2 cm
wound in the right anterior part of chest. She did not care
about it and did not tell anybody because she felt
ashamed. Then neck stiffness and muscle cramp in all
extremities appeared gradually. Her husband sent her to
the infectious hospital at first. The wound was cleaned and
opened. She had been given tetanus antitoxin (1500 u)
and a bolus of tetanus immune globulin (150 u/kg) in the
following three days, but the symptoms developed with
severe myoclonus, autonomic dysfunction and apnea.
Diazepam (10 mg/30 min) was executed several times, but
severe muscle spasms were still uncontrolled. The patient
was in a coma, and the blood oxygen saturation was only
85%, then she was transferred to intensive care unit (ICU).
On admission of ICU, tracheal cannula and ventilator were
given to help her breath. Risus sardonicus, trismus and
opisthotonus could be observed. In a coma her heart rate
was 171 per minute, blood pressure was 117/63 mmHg
and SpO2 fell to 60%. Edema of bulbar conjunctiva was
examined. With low respiratory sounds, crackles were
heard, and the chest X-ray shows pneumonia of the left
lung (Figure 1). Autonomic dysfunction with repetitive
periods of tachycardia and profuse sweating developed.
The elevated white blood cell count was 26.2 × 109/L, AST
was 1454 u/L, LDH was 1127 u/L, CK was 23750 u/L,
CK-MB was 163 u/L, pH 7.267 and the elevated lactic acid
was 6.5 mmol/L. The diagnosis of the patient was severe
tetanus, pneumonia, respiratory failure, myocardial
damage. Propofol (300 mg/h), midazolam (5 mg/h),
lytic cocktail (chlorpromazine 50 mg, pethidine 100 mg
and promethazine 50 mg were dissolved in 50 ml
physiological saline, 2 ml/h), morphine (2 mg/h) were
intravenous administration continuously, and morphine
(2-5 mg), diazepam (5-10 mg), phenobarbital (0.1 g) were
used intravenously intermittently, but spasms and rigidity
couldn’tbecontrolled.Thenvecuroniumbromide(8mg/h)
was administrated. Antibiotic, combination of glucose-
insulin-potassium(GIK) wereusedtotreatpneumoniaand
protect the cardiac. Sodium bicarbonate was also given to
obviateacuterenalfailurewhichwascaused bymyoglobin.
Considering she needed ventilation a long time, we gave
her tracheostomy the next day. To avoid the complications
of tetanus, bronchofibroscope, prone ventilation and lung
recruitment were performed, the concentration of myo-
globin, ALT, CK and CK-MB were still elevated, and the
triglyceride was not elevated obviously in the first week.
Although the patient was sedative deeply and the Ramsay
scale was 6, the symptoms had not been controlled very
Figure 1. Chest X-ray film (the patient on admission of ICU).
The left lung was severe compared to the right lung.
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would occur again, so we had to keep the patient sedated
and observe her physical signs. However, the variability of
blood pressure and heart rate was provoked by minor
stimuli vigorously. Therefore she was given a bolus of
propofol (30 mg) before any therapies.
After the second week in ICU, the hepatic function, the
concentration of myoglobin, CK and CK-MB began to
descend, but the triglyceride was elevated slightly.
Propofol (50-100 mg/h), midazolam (20 mg/h), vecur-
onium bromide (4-6 mg/h) and morphine (2-4 mg/h)
were infused continuously according to the reaction of
the patient.
On 25th day in ICU, the pneumonia was controlled
(Figure 2), spasticity and rigidity subsided, and no severe
complications occurred, but sedatives were still needed
[propofol (50 mg/h), midazolam (20 mg/h), vecuronium
bromide (4 mg/h)]. In this condition, we decided to
withdraw the sedatives gradually. At first midazolam was
decreased to a rate of 10 mg/h, but diaphoresis occurred,
and her heart rate increased to 150 per minute, BP
increased to 180/100 mmHg. Luckily, there were no
spasms. Considering the withdrawal syndrome,
midazolam was increased to 20 mg/h. Then the symptoms
disappeared. The vecuronium bromide infusions were
stopped firstly on a regular basis to ensure optimal
sedation levels and monitor the progression of disease.
While monitoring the symptoms, fluctuations of blood
pressure and heart rate, the dosage of propofol and
midazolam were reduced gradually. Spasms subsided
gradually both in frequency and severity which allowed
the reduction of their infusion rates.
After 5 weeks of intensive care, the patient awakened. We
stopped all of the sedatives gradually, except midazolam
(2-4 mg/h). However, because of lying in bed for nearly
one month her limbs couldn’t move and sometimes
trembled. After stoping using midazolam on the 45th day,
we decided to help the patient to wean from ventilator.
On the 52th day in ICU, she weaned successfully, the
concentration of myoglobin, hepatic function, CK and CK-
MB were normal, and the elevated triglyceride was
1.9 mmol/L. On 57th day, she was decannulated, and
with rehabilitation exercise she could stand and live as
before. No complications were observed.
Discussion
The germinated spore of tetanus bacillus secretes two
toxins: tetanospasmin and tetanolysin. Tetanolysin can
help the diffusion of tetanospasmin under anaerobic
conditions in necrotic or infected tissues which surrounds
the infection area. Tetanospasmin primarily affects
inhibitory neurones, prevents the release of the neuro-
transmitters glycine and g-amino butyric acid, and leads to
failure of inhibition of motor reflex responses to sensory
stimulation [1]. These are the causes for the muscle rigidity
of a tetanic spasm. The worst hazard of tetanus is spasm
especially the uncontrolled one. Spasms may cause
laryngeal obstruction, a reduction in chest wall compli-
ance, and respiratory failure which is the most common
direct cause of death from tetanus [6]. Spasms also cause
aspiration time and again, induce myoglobin to release,
make blood pressure and heart rate fluctuate vigorously,
and pneumonia, acute renal failure and heart failure occur.
In order to prohibit the progression of the disease, three
goals must be achieved. The most important one is the
neutralization of any circulating toxin before spreading to
the central nervous system and producing further effects.
This is accomplished by intravenous and intramuscular
administration of adequate doses of tetanus antitoxin as
soon as possible. The second goal is to control infection to
prevent further production of toxins. The last goal is to
treat spasticity and rigidity. The first two goals may be
achieved easily, but the third one is difficult [4].
A review article discussed the management of tetanus,
which had traditionally been with sedation, anticonvul-
sants, neuromuscular blocking agents, and positive
Figure 2. Chest X-ray film (25 days after on admission of
ICU). Pneumonia was cured.
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tetanus, firstly the environment in which the tetanus lives
should be extinct; secondly the toxins should be elimi-
nated and neutralized; thirdly incision of trachea and
pulmonary ventilation are needed to avoid infection;
finally spasticity and rigidity should be controlled,
otherwise the complication of tetanus will appear. In
this case the patient got infected with tetanus then showed
continuous spasms when she was sent to ICU. There was
high level of myoglobin in blood, pneumonia and hepatic
function injured. Fortunately, renal failure and heart
failure did not occur.
It is necessary to give the patient enough sedation to
control the spasticity and rigidity. The choice of sedatives
is difficult sometimes. The sedatives which can block the
toxins to the acceptors should be used. Diazepam
compared to other drugs has the advantages of combined
anticonvulsant, muscle relaxant, sedative and anxiolytic
effects. In 2004 Okoromah CN did a randomized and
quasi-randomized controlled trial, meta-analysis of
in-hospital deaths indicated that children treated with
diazepam alone had more chance of survival than those
treated with combination of phenobarbitone and chlor-
promazine [8]. Also in 2004, Ismoedijanto treated the
children with severe tetanus using high dose diazepam, he
suggested that the dose of diazepam exceeds 240 mg per
day to a child, and a ventilator should be on hand and if
the dose required is more than 480 mg per day, other
drugs should be considered [9]. But single sedative can’tb e
efficient in controlling the spasticity and rigidity for adult.
Drug combination is the only way to control the
symptoms. Benzodiazepines, propofol, morphine, muscle
relaxant and other sedatives should be considered.
Some other medicines are also used for controlling the
symptoms of tetanus. In 2005, Beecroft used remifentanil
infusion which was started at a rate of 0.05-0.1 mg/kg.min
as an adjunct to sedation and for analgesia, and the
infusion rate was increased 1 mg before any therapy, and
titrated to effect (0.3-0.6 mg/kg.min) to control spasms
very well and withdraw the other medicines gradually
[10]. In 2006, Dr CL Thwaites did a randomised, double
blind placebo controlled trial in 256 Vietnamese patients.
Participants were randomly assigned magnesium sulphate
(n = 97) or placebo solution (n = 98) intravenously for
7 days. The result showed that magnesium infusion did
not reduce the need for mechanical ventilation in adults
with severe tetanus but reduced the requirement for other
drugs to control muscle spasms and cardiovascular
instability [11].
But what are the appropriate doses of sedatives? Do high
doses of sedatives bring the side-effect to the patients? In
specifications of drugs, high doses of propofol could bring
hyperlipidemia and propofol infusion syndrome, while
high doses of vecuronium bromide could induce neuro-
muscular blockade and respiratory dysfunction. There are
no instructions guiding doctors to give the proper doses to
this kind of patients. In 1988, Helsinki University Central
Hospital treated an adult patient of severe tetanus with
long-term infusions of propofol (20-80 mg/h, 11 days)
and midazolam (5-15 mg/h, 29 days) for sedation, and
with vecuronium infusion (6-8 mg/h, 35 days) for muscle
relaxation. The patient recovered, but he was unable to
recall anything about his stay in the ICU [5]. The patient in
our ICU was treated with long-term infusions of propofol
(50-100 mg/h, 22 days) and midazolam (5-20 mg/h,
37 days) for sedation, and with vecuronium infusion
(1-6 mg/h, 25 days) for muscle relaxation. The patient was
not found tolerance to propofol, but when we decided to
withdraw midazolam, withdrawal syndrome occurred, we
thought she develop tolerance to midazolam. Propofol
infusion syndrome also was not found, cardiac function
and hepatic function were not aggravation with the
recovery of tetanus. But the triglyceride was elevated
slightly.
It’s difficult to assess the degree of sedation. According to
the guideline of sedation, the sedation goal or endpoint
should be established and redefined regularly. Regular
assessment and patients’ response to therapy should be
systematically documented [12]. But the degree of seda-
tion of these patients can’t be judged by Ramsay scale as
usual. Patients who cannot communicate with others
should be assessed through subjective observation of pain-
related behaviors (movement, facial expression, and
posturing) and physiological indicators (heart rate,
blood pressure, and respiratory rate) and changes of
their physical parameters.
Conclusion
We report one case of severe tetanus. In this case several
sedatives were administrated and most of them were high
doses. The patient recovered while no complications
remained. For spasticity and rigidity induced by severe
tetanus, combinations and high doses of sedatives should
be considered and subjective observation, physiological
indicators and changes of their physical parameters can be
used to access the degrees of sedation. The proposal of
combining overdosage of several sedatives is available in
treatment of patients with this kind of symptom.
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